Insights On Trial Design

  1. 5 Questions To Ask Before Selecting A Randomization Partner 5/12/2026

    Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

  2. Improving The Patient Experience In Clinical Research 2/6/2025

    To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

  3. The Real Payoff Of Reusable IRT/RTSM System Design 2/27/2026

    By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.

  4. Participants Don't Care How Your Vendor Stack Works 6/16/2026

    Participants experience one study, not the vendor stack behind it. Learn how sponsors and CROs can reduce burden with support built around real study needs.

  5. How Early-Stage Planning Strategies Are Optimizing Drug Development 5/12/2025

    Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

  6. AI's Bottleneck In Clinical Trials Moved, And Most People Missed It 7/20/2026

    AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.

  7. Accelerate Drug Development With Master Protocols 5/15/2025

    Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

  8. Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials 1/30/2025

    Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.

  9. Optimize Protocols For More Successful Trials 9/17/2024

    Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.

  10. DCTs And Community-Based Research Execution And Compliance 5/28/2025

    The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.